🇺🇸 FDA
Patent

US 8455652

Inhibitors for the soluble epoxide hydrolase

granted A61PA61P11/00A61P11/06

Quick answer

US patent 8455652 (Inhibitors for the soluble epoxide hydrolase) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61P, A61P11/00, A61P11/06, A61P13/12, A61P19/02